Global Genetic Modification Therapies Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Genetic Modification Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genetic Modification Therapies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Genetic Modification Therapies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gene Therapies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genetic Modification Therapies include 4D Molecular Therapeutics, Abeona Therapeutics, Allergan, American Gene Technologies, and Merck Millipore, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genetic Modification Therapies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Genetic Modification Therapies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Modification Therapies, with revenue, gross margin and global market share of Genetic Modification Therapies from 2019 to 2022.
Chapter 3, the Genetic Modification Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Modification Therapies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genetic Modification Therapies research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genetic Modification Therapies market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Genetic Modification Therapies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Gene Therapies segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Genetic Modification Therapies include 4D Molecular Therapeutics, Abeona Therapeutics, Allergan, American Gene Technologies, and Merck Millipore, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genetic Modification Therapies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Gene Therapies
- Genetically Modified Cell Therapies
- RNA Therapies
- Gene Editing
- Hospitals
- Diagnostics and Testing Laboratories
- Academic and Research Organizations
- Others
- 4D Molecular Therapeutics
- Abeona Therapeutics
- Allergan
- American Gene Technologies
- Merck Millipore
- AbbVie
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Genetic Modification Therapies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genetic Modification Therapies, with revenue, gross margin and global market share of Genetic Modification Therapies from 2019 to 2022.
Chapter 3, the Genetic Modification Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Genetic Modification Therapies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Genetic Modification Therapies research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Genetic Modification Therapies
1.2 Classification of Genetic Modification Therapies by Type
1.2.1 Overview: Global Genetic Modification Therapies Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genetic Modification Therapies Revenue Market Share by Type in 2021
1.2.3 Gene Therapies
1.2.4 Genetically Modified Cell Therapies
1.2.5 RNA Therapies
1.2.6 Gene Editing
1.3 Global Genetic Modification Therapies Market by Application
1.3.1 Overview: Global Genetic Modification Therapies Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Genetic Modification Therapies Market Size & Forecast
1.5 Global Genetic Modification Therapies Market Size and Forecast by Region
1.5.1 Global Genetic Modification Therapies Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genetic Modification Therapies Market Size by Region, (2017-2022)
1.5.3 North America Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.4 Europe Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.6 South America Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Modification Therapies Market Drivers
1.6.2 Genetic Modification Therapies Market Restraints
1.6.3 Genetic Modification Therapies Trends Analysis
2 COMPANY PROFILES
2.1 4D Molecular Therapeutics
2.1.1 4D Molecular Therapeutics Details
2.1.2 4D Molecular Therapeutics Major Business
2.1.3 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
2.1.4 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 4D Molecular Therapeutics Recent Developments and Future Plans
2.2 Abeona Therapeutics
2.2.1 Abeona Therapeutics Details
2.2.2 Abeona Therapeutics Major Business
2.2.3 Abeona Therapeutics Genetic Modification Therapies Product and Solutions
2.2.4 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abeona Therapeutics Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Genetic Modification Therapies Product and Solutions
2.3.4 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Allergan Recent Developments and Future Plans
2.4 American Gene Technologies
2.4.1 American Gene Technologies Details
2.4.2 American Gene Technologies Major Business
2.4.3 American Gene Technologies Genetic Modification Therapies Product and Solutions
2.4.4 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 American Gene Technologies Recent Developments and Future Plans
2.5 Merck Millipore
2.5.1 Merck Millipore Details
2.5.2 Merck Millipore Major Business
2.5.3 Merck Millipore Genetic Modification Therapies Product and Solutions
2.5.4 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Merck Millipore Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Genetic Modification Therapies Product and Solutions
2.6.4 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 AbbVie Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Modification Therapies Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Modification Therapies Players Market Share in 2021
3.2.2 Top 10 Genetic Modification Therapies Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genetic Modification Therapies Players Head Office, Products and Services Provided
3.4 Genetic Modification Therapies Mergers & Acquisitions
3.5 Genetic Modification Therapies New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Modification Therapies Revenue and Market Share by Type (2017-2022)
4.2 Global Genetic Modification Therapies Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Modification Therapies Revenue Market Share by Application (2017-2022)
5.2 Global Genetic Modification Therapies Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Genetic Modification Therapies Revenue by Type (2017-2028)
6.2 North America Genetic Modification Therapies Revenue by Application (2017-2028)
6.3 North America Genetic Modification Therapies Market Size by Country
6.3.1 North America Genetic Modification Therapies Revenue by Country (2017-2028)
6.3.2 United States Genetic Modification Therapies Market Size and Forecast (2017-2028)
6.3.3 Canada Genetic Modification Therapies Market Size and Forecast (2017-2028)
6.3.4 Mexico Genetic Modification Therapies Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Genetic Modification Therapies Revenue by Type (2017-2028)
7.2 Europe Genetic Modification Therapies Revenue by Application (2017-2028)
7.3 Europe Genetic Modification Therapies Market Size by Country
7.3.1 Europe Genetic Modification Therapies Revenue by Country (2017-2028)
7.3.2 Germany Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.3 France Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.5 Russia Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.6 Italy Genetic Modification Therapies Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Genetic Modification Therapies Revenue by Type (2017-2028)
8.2 Asia-Pacific Genetic Modification Therapies Revenue by Application (2017-2028)
8.3 Asia-Pacific Genetic Modification Therapies Market Size by Region
8.3.1 Asia-Pacific Genetic Modification Therapies Revenue by Region (2017-2028)
8.3.2 China Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.3 Japan Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.4 South Korea Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.5 India Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.7 Australia Genetic Modification Therapies Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Genetic Modification Therapies Revenue by Type (2017-2028)
9.2 South America Genetic Modification Therapies Revenue by Application (2017-2028)
9.3 South America Genetic Modification Therapies Market Size by Country
9.3.1 South America Genetic Modification Therapies Revenue by Country (2017-2028)
9.3.2 Brazil Genetic Modification Therapies Market Size and Forecast (2017-2028)
9.3.3 Argentina Genetic Modification Therapies Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Genetic Modification Therapies Revenue by Type (2017-2028)
10.2 Middle East & Africa Genetic Modification Therapies Revenue by Application (2017-2028)
10.3 Middle East & Africa Genetic Modification Therapies Market Size by Country
10.3.1 Middle East & Africa Genetic Modification Therapies Revenue by Country (2017-2028)
10.3.2 Turkey Genetic Modification Therapies Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genetic Modification Therapies Market Size and Forecast (2017-2028)
10.3.4 UAE Genetic Modification Therapies Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Genetic Modification Therapies
1.2 Classification of Genetic Modification Therapies by Type
1.2.1 Overview: Global Genetic Modification Therapies Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Genetic Modification Therapies Revenue Market Share by Type in 2021
1.2.3 Gene Therapies
1.2.4 Genetically Modified Cell Therapies
1.2.5 RNA Therapies
1.2.6 Gene Editing
1.3 Global Genetic Modification Therapies Market by Application
1.3.1 Overview: Global Genetic Modification Therapies Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Diagnostics and Testing Laboratories
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Genetic Modification Therapies Market Size & Forecast
1.5 Global Genetic Modification Therapies Market Size and Forecast by Region
1.5.1 Global Genetic Modification Therapies Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Genetic Modification Therapies Market Size by Region, (2017-2022)
1.5.3 North America Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.4 Europe Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.6 South America Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Genetic Modification Therapies Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Genetic Modification Therapies Market Drivers
1.6.2 Genetic Modification Therapies Market Restraints
1.6.3 Genetic Modification Therapies Trends Analysis
2 COMPANY PROFILES
2.1 4D Molecular Therapeutics
2.1.1 4D Molecular Therapeutics Details
2.1.2 4D Molecular Therapeutics Major Business
2.1.3 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
2.1.4 4D Molecular Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 4D Molecular Therapeutics Recent Developments and Future Plans
2.2 Abeona Therapeutics
2.2.1 Abeona Therapeutics Details
2.2.2 Abeona Therapeutics Major Business
2.2.3 Abeona Therapeutics Genetic Modification Therapies Product and Solutions
2.2.4 Abeona Therapeutics Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abeona Therapeutics Recent Developments and Future Plans
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business
2.3.3 Allergan Genetic Modification Therapies Product and Solutions
2.3.4 Allergan Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Allergan Recent Developments and Future Plans
2.4 American Gene Technologies
2.4.1 American Gene Technologies Details
2.4.2 American Gene Technologies Major Business
2.4.3 American Gene Technologies Genetic Modification Therapies Product and Solutions
2.4.4 American Gene Technologies Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 American Gene Technologies Recent Developments and Future Plans
2.5 Merck Millipore
2.5.1 Merck Millipore Details
2.5.2 Merck Millipore Major Business
2.5.3 Merck Millipore Genetic Modification Therapies Product and Solutions
2.5.4 Merck Millipore Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Merck Millipore Recent Developments and Future Plans
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business
2.6.3 AbbVie Genetic Modification Therapies Product and Solutions
2.6.4 AbbVie Genetic Modification Therapies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 AbbVie Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Modification Therapies Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Genetic Modification Therapies Players Market Share in 2021
3.2.2 Top 10 Genetic Modification Therapies Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Genetic Modification Therapies Players Head Office, Products and Services Provided
3.4 Genetic Modification Therapies Mergers & Acquisitions
3.5 Genetic Modification Therapies New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Modification Therapies Revenue and Market Share by Type (2017-2022)
4.2 Global Genetic Modification Therapies Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Modification Therapies Revenue Market Share by Application (2017-2022)
5.2 Global Genetic Modification Therapies Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Genetic Modification Therapies Revenue by Type (2017-2028)
6.2 North America Genetic Modification Therapies Revenue by Application (2017-2028)
6.3 North America Genetic Modification Therapies Market Size by Country
6.3.1 North America Genetic Modification Therapies Revenue by Country (2017-2028)
6.3.2 United States Genetic Modification Therapies Market Size and Forecast (2017-2028)
6.3.3 Canada Genetic Modification Therapies Market Size and Forecast (2017-2028)
6.3.4 Mexico Genetic Modification Therapies Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Genetic Modification Therapies Revenue by Type (2017-2028)
7.2 Europe Genetic Modification Therapies Revenue by Application (2017-2028)
7.3 Europe Genetic Modification Therapies Market Size by Country
7.3.1 Europe Genetic Modification Therapies Revenue by Country (2017-2028)
7.3.2 Germany Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.3 France Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.5 Russia Genetic Modification Therapies Market Size and Forecast (2017-2028)
7.3.6 Italy Genetic Modification Therapies Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Genetic Modification Therapies Revenue by Type (2017-2028)
8.2 Asia-Pacific Genetic Modification Therapies Revenue by Application (2017-2028)
8.3 Asia-Pacific Genetic Modification Therapies Market Size by Region
8.3.1 Asia-Pacific Genetic Modification Therapies Revenue by Region (2017-2028)
8.3.2 China Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.3 Japan Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.4 South Korea Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.5 India Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Genetic Modification Therapies Market Size and Forecast (2017-2028)
8.3.7 Australia Genetic Modification Therapies Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Genetic Modification Therapies Revenue by Type (2017-2028)
9.2 South America Genetic Modification Therapies Revenue by Application (2017-2028)
9.3 South America Genetic Modification Therapies Market Size by Country
9.3.1 South America Genetic Modification Therapies Revenue by Country (2017-2028)
9.3.2 Brazil Genetic Modification Therapies Market Size and Forecast (2017-2028)
9.3.3 Argentina Genetic Modification Therapies Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Genetic Modification Therapies Revenue by Type (2017-2028)
10.2 Middle East & Africa Genetic Modification Therapies Revenue by Application (2017-2028)
10.3 Middle East & Africa Genetic Modification Therapies Market Size by Country
10.3.1 Middle East & Africa Genetic Modification Therapies Revenue by Country (2017-2028)
10.3.2 Turkey Genetic Modification Therapies Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Genetic Modification Therapies Market Size and Forecast (2017-2028)
10.3.4 UAE Genetic Modification Therapies Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Genetic Modification Therapies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genetic Modification Therapies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genetic Modification Therapies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genetic Modification Therapies Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genetic Modification Therapies Revenue Market Share by Region (2023-2028)
Table 6. 4D Molecular Therapeutics Corporate Information, Head Office, and Major Competitors
Table 7. 4D Molecular Therapeutics Major Business
Table 8. 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
Table 9. 4D Molecular Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abeona Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Abeona Therapeutics Major Business
Table 12. Abeona Therapeutics Genetic Modification Therapies Product and Solutions
Table 13. Abeona Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Allergan Corporate Information, Head Office, and Major Competitors
Table 15. Allergan Major Business
Table 16. Allergan Genetic Modification Therapies Product and Solutions
Table 17. Allergan Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. American Gene Technologies Corporate Information, Head Office, and Major Competitors
Table 19. American Gene Technologies Major Business
Table 20. American Gene Technologies Genetic Modification Therapies Product and Solutions
Table 21. American Gene Technologies Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Merck Millipore Corporate Information, Head Office, and Major Competitors
Table 23. Merck Millipore Major Business
Table 24. Merck Millipore Genetic Modification Therapies Product and Solutions
Table 25. Merck Millipore Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. AbbVie Corporate Information, Head Office, and Major Competitors
Table 27. AbbVie Major Business
Table 28. AbbVie Genetic Modification Therapies Product and Solutions
Table 29. AbbVie Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Global Genetic Modification Therapies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 31. Global Genetic Modification Therapies Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 32. Breakdown of Genetic Modification Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Genetic Modification Therapies Players Head Office, Products and Services Provided
Table 34. Genetic Modification Therapies Mergers & Acquisitions in the Past Five Years
Table 35. Genetic Modification Therapies New Entrants and Expansion Plans
Table 36. Global Genetic Modification Therapies Revenue (USD Million) by Type (2017-2022)
Table 37. Global Genetic Modification Therapies Revenue Share by Type (2017-2022)
Table 38. Global Genetic Modification Therapies Revenue Forecast by Type (2023-2028)
Table 39. Global Genetic Modification Therapies Revenue by Application (2017-2022)
Table 40. Global Genetic Modification Therapies Revenue Forecast by Application (2023-2028)
Table 41. North America Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 42. North America Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 43. North America Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 44. North America Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 45. North America Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 46. North America Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 47. Europe Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 48. Europe Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 49. Europe Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 50. Europe Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 51. Europe Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 52. Europe Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 53. Asia-Pacific Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 54. Asia-Pacific Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 55. Asia-Pacific Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 56. Asia-Pacific Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 57. Asia-Pacific Genetic Modification Therapies Revenue by Region (2017-2022) & (USD Million)
Table 58. Asia-Pacific Genetic Modification Therapies Revenue by Region (2023-2028) & (USD Million)
Table 59. South America Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 60. South America Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 61. South America Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 62. South America Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 63. South America Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 64. South America Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 65. Middle East & Africa Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 66. Middle East & Africa Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 67. Middle East & Africa Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 68. Middle East & Africa Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 69. Middle East & Africa Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 70. Middle East & Africa Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Genetic Modification Therapies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Genetic Modification Therapies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Genetic Modification Therapies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Genetic Modification Therapies Revenue (USD Million) by Region (2017-2022)
Table 5. Global Genetic Modification Therapies Revenue Market Share by Region (2023-2028)
Table 6. 4D Molecular Therapeutics Corporate Information, Head Office, and Major Competitors
Table 7. 4D Molecular Therapeutics Major Business
Table 8. 4D Molecular Therapeutics Genetic Modification Therapies Product and Solutions
Table 9. 4D Molecular Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abeona Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. Abeona Therapeutics Major Business
Table 12. Abeona Therapeutics Genetic Modification Therapies Product and Solutions
Table 13. Abeona Therapeutics Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Allergan Corporate Information, Head Office, and Major Competitors
Table 15. Allergan Major Business
Table 16. Allergan Genetic Modification Therapies Product and Solutions
Table 17. Allergan Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. American Gene Technologies Corporate Information, Head Office, and Major Competitors
Table 19. American Gene Technologies Major Business
Table 20. American Gene Technologies Genetic Modification Therapies Product and Solutions
Table 21. American Gene Technologies Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Merck Millipore Corporate Information, Head Office, and Major Competitors
Table 23. Merck Millipore Major Business
Table 24. Merck Millipore Genetic Modification Therapies Product and Solutions
Table 25. Merck Millipore Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. AbbVie Corporate Information, Head Office, and Major Competitors
Table 27. AbbVie Major Business
Table 28. AbbVie Genetic Modification Therapies Product and Solutions
Table 29. AbbVie Genetic Modification Therapies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Global Genetic Modification Therapies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 31. Global Genetic Modification Therapies Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 32. Breakdown of Genetic Modification Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Genetic Modification Therapies Players Head Office, Products and Services Provided
Table 34. Genetic Modification Therapies Mergers & Acquisitions in the Past Five Years
Table 35. Genetic Modification Therapies New Entrants and Expansion Plans
Table 36. Global Genetic Modification Therapies Revenue (USD Million) by Type (2017-2022)
Table 37. Global Genetic Modification Therapies Revenue Share by Type (2017-2022)
Table 38. Global Genetic Modification Therapies Revenue Forecast by Type (2023-2028)
Table 39. Global Genetic Modification Therapies Revenue by Application (2017-2022)
Table 40. Global Genetic Modification Therapies Revenue Forecast by Application (2023-2028)
Table 41. North America Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 42. North America Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 43. North America Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 44. North America Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 45. North America Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 46. North America Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 47. Europe Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 48. Europe Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 49. Europe Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 50. Europe Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 51. Europe Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 52. Europe Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 53. Asia-Pacific Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 54. Asia-Pacific Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 55. Asia-Pacific Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 56. Asia-Pacific Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 57. Asia-Pacific Genetic Modification Therapies Revenue by Region (2017-2022) & (USD Million)
Table 58. Asia-Pacific Genetic Modification Therapies Revenue by Region (2023-2028) & (USD Million)
Table 59. South America Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 60. South America Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 61. South America Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 62. South America Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 63. South America Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 64. South America Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
Table 65. Middle East & Africa Genetic Modification Therapies Revenue by Type (2017-2022) & (USD Million)
Table 66. Middle East & Africa Genetic Modification Therapies Revenue by Type (2023-2028) & (USD Million)
Table 67. Middle East & Africa Genetic Modification Therapies Revenue by Application (2017-2022) & (USD Million)
Table 68. Middle East & Africa Genetic Modification Therapies Revenue by Application (2023-2028) & (USD Million)
Table 69. Middle East & Africa Genetic Modification Therapies Revenue by Country (2017-2022) & (USD Million)
Table 70. Middle East & Africa Genetic Modification Therapies Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Genetic Modification Therapies Picture
Figure 2. Global Genetic Modification Therapies Revenue Market Share by Type in 2021
Figure 3. Gene Therapies
Figure 4. Genetically Modified Cell Therapies
Figure 5. RNA Therapies
Figure 6. Gene Editing
Figure 7. Genetic Modification Therapies Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Diagnostics and Testing Laboratories Picture
Figure 10. Academic and Research Organizations Picture
Figure 11. Others Picture
Figure 12. Global Genetic Modification Therapies Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Genetic Modification Therapies Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Genetic Modification Therapies Revenue Market Share by Region (2017-2028)
Figure 15. Global Genetic Modification Therapies Revenue Market Share by Region in 2021
Figure 16. North America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Genetic Modification Therapies Market Drivers
Figure 22. Genetic Modification Therapies Market Restraints
Figure 23. Genetic Modification Therapies Market Trends
Figure 24. 4D Molecular Therapeutics Recent Developments and Future Plans
Figure 25. Abeona Therapeutics Recent Developments and Future Plans
Figure 26. Allergan Recent Developments and Future Plans
Figure 27. American Gene Technologies Recent Developments and Future Plans
Figure 28. Merck Millipore Recent Developments and Future Plans
Figure 29. AbbVie Recent Developments and Future Plans
Figure 30. Global Genetic Modification Therapies Revenue Share by Players in 2021
Figure 31. Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Genetic Modification Therapies Revenue Market Share in 2021
Figure 33. Global Top 10 Players Genetic Modification Therapies Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Genetic Modification Therapies Revenue Share by Type in 2021
Figure 36. Global Genetic Modification Therapies Market Share Forecast by Type (2023-2028)
Figure 37. Global Genetic Modification Therapies Revenue Share by Application in 2021
Figure 38. Global Genetic Modification Therapies Market Share Forecast by Application (2023-2028)
Figure 39. North America Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 40. North America Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 41. North America Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 42. United States Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 46. Europe Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 47. Europe Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 48. Germany Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Genetic Modification Therapies Revenue Market Share by Region (2017-2028)
Figure 56. China Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 63. South America Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 64. South America Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Genetic Modification Therapies Picture
Figure 2. Global Genetic Modification Therapies Revenue Market Share by Type in 2021
Figure 3. Gene Therapies
Figure 4. Genetically Modified Cell Therapies
Figure 5. RNA Therapies
Figure 6. Gene Editing
Figure 7. Genetic Modification Therapies Revenue Market Share by Application in 2021
Figure 8. Hospitals Picture
Figure 9. Diagnostics and Testing Laboratories Picture
Figure 10. Academic and Research Organizations Picture
Figure 11. Others Picture
Figure 12. Global Genetic Modification Therapies Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Genetic Modification Therapies Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Genetic Modification Therapies Revenue Market Share by Region (2017-2028)
Figure 15. Global Genetic Modification Therapies Revenue Market Share by Region in 2021
Figure 16. North America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Genetic Modification Therapies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Genetic Modification Therapies Market Drivers
Figure 22. Genetic Modification Therapies Market Restraints
Figure 23. Genetic Modification Therapies Market Trends
Figure 24. 4D Molecular Therapeutics Recent Developments and Future Plans
Figure 25. Abeona Therapeutics Recent Developments and Future Plans
Figure 26. Allergan Recent Developments and Future Plans
Figure 27. American Gene Technologies Recent Developments and Future Plans
Figure 28. Merck Millipore Recent Developments and Future Plans
Figure 29. AbbVie Recent Developments and Future Plans
Figure 30. Global Genetic Modification Therapies Revenue Share by Players in 2021
Figure 31. Genetic Modification Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Genetic Modification Therapies Revenue Market Share in 2021
Figure 33. Global Top 10 Players Genetic Modification Therapies Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Genetic Modification Therapies Revenue Share by Type in 2021
Figure 36. Global Genetic Modification Therapies Market Share Forecast by Type (2023-2028)
Figure 37. Global Genetic Modification Therapies Revenue Share by Application in 2021
Figure 38. Global Genetic Modification Therapies Market Share Forecast by Application (2023-2028)
Figure 39. North America Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 40. North America Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 41. North America Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 42. United States Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 46. Europe Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 47. Europe Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 48. Germany Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Genetic Modification Therapies Revenue Market Share by Region (2017-2028)
Figure 56. China Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 63. South America Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 64. South America Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Genetic Modification Therapies Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Genetic Modification Therapies Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Genetic Modification Therapies Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Genetic Modification Therapies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
